Microbix Biosystems Inc.
MBX.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -758.51% | -94.86% | -66.08% | -78.32% | 131.49% |
| Total Depreciation and Amortization | 3.11% | -0.50% | 1.67% | 111.05% | 37.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -75.43% | -- |
| Total Other Non-Cash Items | 131.38% | -13.95% | -5.41% | 109.00% | -58.44% |
| Change in Net Operating Assets | -267.09% | 193.10% | 57.13% | 66.04% | -74.20% |
| Cash from Operations | -235.56% | 8.21% | -42.46% | 151.73% | -35.35% |
| Capital Expenditure | 73.70% | 63.88% | -437.41% | -91.47% | -234.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.80% | 63.88% | -437.41% | -91.47% | -357.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 82.51% | -1,568.76% | 0.14% | 0.00% | -312.13% |
| Issuance of Common Stock | -- | 665.97% | -- | -- | -- |
| Repurchase of Common Stock | -64.02% | -88.38% | -872.05% | -67.20% | 2.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.07% | 750.49% | -289.95% | -64.32% | -99.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,648.94% | 1,452.62% | -93.00% | 108.43% | -103.74% |